Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (371)
Candel Therapeutics, Inc. (CADL)
Tyagarajan Seshu — Chief Technology Officer
Shares
7,000
Price
$10.02
Total Value
$70.15K
Shares Held After
83,865
% of Holdings
7.7%
Candel Therapeutics, Inc. (CADL)
Barone Francesca — Chief Scientific Officer
Shares
23,447
Price
$10.06
Total Value
$235.77K
Shares Held After
77,362
% of Holdings
23.3%
Protara Therapeutics, Inc. (TARA)
Shefferman Jesse — Director
Shares
215,687
Price
$4.09
Total Value
$882.16K
Shares Held After
721,832
% of Holdings
23.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$28.02
Total Value
$210.15K
Shares Held After
26,250
% of Holdings
22.2%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
42,350
Price
$25.21
Total Value
$1.07M
Shares Held After
0
% of Holdings
100.0%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
25,000
Price
$2.60
Total Value
$65.00K
Shares Held After
373,322
% of Holdings
6.7%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Climb Bio, Inc. (CLYM)
Brennan Aoife — Director
Shares
30,902
Price
$13.17
Total Value
$406.98K
Shares Held After
87,731
% of Holdings
26.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
BENZENO SHARON — Chief Commercial Ofc Imm Med
Shares
154,768
Price
$21.14
Total Value
$3.27M
Shares Held After
221,278
% of Holdings
41.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
40,702
Price
$21.14
Total Value
$860.44K
Shares Held After
975,931
% of Holdings
4.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
51,756
Price
$21.14
Total Value
$1.09M
Shares Held After
1,344,719
% of Holdings
3.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
102,969
Price
$21.14
Total Value
$2.18M
Shares Held After
4,476,487
% of Holdings
2.2%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
47,467
Price
$5.04
Total Value
$239.23K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Shlevin Harold H. — Director
Shares
22,268
Price
$5.04
Total Value
$112.23K
Shares Held After
6,500
% of Holdings
77.4%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
2,178
Price
$35.18
Total Value
$76.62K
Shares Held After
793
% of Holdings
73.3%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
1,649
Price
$75.00
Total Value
$123.67K
Shares Held After
52,173
% of Holdings
3.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,024
Price
$107.76
Total Value
$325.87K
Shares Held After
466,077
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,318
Price
$106.63
Total Value
$247.17K
Shares Held After
469,101
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
848
Price
$105.78
Total Value
$89.70K
Shares Held After
471,419
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
19,093
Price
$107.76
Total Value
$2.06M
Shares Held After
2,412,747
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,613
Price
$106.63
Total Value
$1.56M
Shares Held After
2,431,840
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,471
Price
$105.78
Total Value
$578.72K
Shares Held After
2,446,453
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Krishnan Mahesh — Director
Shares
7,304
Price
$75.00
Total Value
$547.80K
Shares Held After
14,462
% of Holdings
33.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
157
Price
$111.20
Total Value
$17.46K
Shares Held After
461,794
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,199
Price
$110.67
Total Value
$132.69K
Shares Held After
461,951
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,239
Price
$109.75
Total Value
$135.98K
Shares Held After
463,150
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,688
Price
$108.28
Total Value
$182.78K
Shares Held After
464,389
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
907
Price
$111.20
Total Value
$100.86K
Shares Held After
2,385,747
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,602
Price
$110.67
Total Value
$841.31K
Shares Held After
2,386,654
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,833
Price
$109.75
Total Value
$859.67K
Shares Held After
2,394,256
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,658
Price
$108.28
Total Value
$1.15M
Shares Held After
2,402,089
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
430
Price
$548.96
Total Value
$236.05K
Shares Held After
40,513
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,702
Price
$548.29
Total Value
$933.19K
Shares Held After
40,943
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
759
Price
$547.12
Total Value
$415.26K
Shares Held After
42,645
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,705
Price
$546.28
Total Value
$931.40K
Shares Held After
43,404
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,165
Price
$545.30
Total Value
$1.18M
Shares Held After
45,109
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,594
Price
$544.40
Total Value
$867.78K
Shares Held After
47,274
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
585
Price
$543.37
Total Value
$317.87K
Shares Held After
48,868
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$541.86
Total Value
$43.35K
Shares Held After
49,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$541.24
Total Value
$194.85K
Shares Held After
49,533
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$539.98
Total Value
$64.80K
Shares Held After
49,893
% of Holdings
0.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Manning Anthony M. — Director
Shares
10,000
Price
$23.11
Total Value
$231.10K
Shares Held After
0
% of Holdings
100.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
6,000
Price
$22.95
Total Value
$137.70K
Shares Held After
59,992
% of Holdings
9.1%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
777
Price
$2.48
Total Value
$1.93K
Shares Held After
2,533,845
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
63,985
Price
$2.47
Total Value
$158.04K
Shares Held After
2,533,068
% of Holdings
2.5%
Showing 1–50 of 371 transactions (page 1 of 8)